ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,260,000 | -69.4% | 9,779 | -60.3% | 0.03% | -68.8% |
| Q4 2020 | $4,112,000 | +70.2% | 24,653 | +57.4% | 0.09% | +1.1% |
| Q3 2020 | $2,416,000 | -39.5% | 15,659 | -42.0% | 0.09% | -54.7% |
| Q2 2020 | $3,995,000 | +840.0% | 27,009 | +614.9% | 0.20% | +625.0% |
| Q1 2020 | $425,000 | -87.4% | 3,778 | -84.4% | 0.03% | -81.8% |
| Q4 2019 | $3,378,000 | +112.1% | 24,283 | +46.8% | 0.15% | +51.0% |
| Q3 2019 | $1,593,000 | +68.8% | 16,538 | +101.7% | 0.10% | -15.7% |
| Q2 2019 | $944,000 | +321.4% | 8,200 | +331.6% | 0.12% | +227.0% |
| Q1 2019 | $224,000 | – | 1,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,225,357 | $1,001,863,112 | 18.92% |
| Q Global Advisors, LLC | 195,000 | $17,404 | 12.55% |
| Sofinnova Investments, Inc. | 754,032 | $67,297,356 | 4.41% |
| Avoro Capital Advisors LLC | 3,580,555 | $319,564,534 | 4.34% |
| Finepoint Capital LP | 139,772 | $12,474,651 | 4.32% |
| Spyglass Capital Management LLC | 657,853 | $58,713,380 | 4.24% |
| Saturn V Capital Management LP | 78,442 | $7,000,948 | 3.88% |
| DAFNA Capital Management LLC | 135,212 | $12,067,671 | 3.30% |
| ARS Investment Partners, LLC | 289,860 | $25,870,005 | 3.02% |
| Ghost Tree Capital, LLC | 100,000 | $8,925,000 | 2.95% |